Dishman Carbogen Amcis Limited (NSE:DCAL)
India · Delayed Price · Currency is INR 129.25
-13.44 (-9.42%)
Mar 30, 2026, 3:29 PM IST
Dishman Carbogen Amcis Market Cap
Dishman Carbogen Amcis has a market cap or net worth of 22.37 billion as of March 30, 2026. Its market cap has decreased by -33.28% in one year.
Market Cap
22.37B
Enterprise Value
41.64B
Revenue
27.97B
Ranking
n/a
PE Ratio
18.82
Stock Price
129.25
Market Cap Chart
Since September 21, 2017, Dishman Carbogen Amcis's market cap has decreased from 56.82B to 22.37B, a decrease of -60.63%. That is a compound annual growth rate of -10.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 22.37B | -42.37% |
| Dec 31, 2025 | 38.82B | -8.46% |
| Dec 31, 2024 | 42.41B | 58.22% |
| Dec 29, 2023 | 26.80B | 80.14% |
| Dec 30, 2022 | 14.88B | -52.91% |
| Dec 31, 2021 | 31.60B | 45.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 598.96B |
| Anthem Biosciences | 382.71B |
| OneSource Specialty Pharma | 165.87B |
| Concord Biotech | 106.16B |
| Blue Jet Healthcare | 59.64B |
| Supriya Lifescience | 47.29B |
| Zota Health Care | 35.82B |
| Panacea Biotec | 19.59B |